{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:21:39Z","timestamp":1772058099012,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science and Technology Development Project","award":["140901GX010013647"],"award-info":[{"award-number":["140901GX010013647"]}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.xphs.2019.02.017","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T12:47:17Z","timestamp":1551358037000},"page":"2315-2322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development of a Stable Liquid Formulation for Live Attenuated Influenza Vaccine"],"prefix":"10.1016","volume":"108","author":[{"given":"Yao","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanming","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2019.02.017_bib1","series-title":"Fact Sheet No. 211: Influenza (Seasonal)","year":"2009"},{"key":"10.1016\/j.xphs.2019.02.017_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.xphs.2019.02.017_bib3","series-title":"Report of the Second WHO Consultation on the Global Action Plan for Influenza Vaccines (GAP)","year":"2012"},{"key":"10.1016\/j.xphs.2019.02.017_bib4","series-title":"Global Action Plan on Influenza Vaccines (GAP): Global Progress Report 2006\u20132013","year":"2014"},{"key":"10.1016\/j.xphs.2019.02.017_bib5","series-title":"Global Action Plan on Influenza Vaccines","year":"2006"},{"issue":"7","key":"10.1016\/j.xphs.2019.02.017_bib6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1586\/14760584.2014.922417","article-title":"Development of live attenuated influenza vaccines against pandemic influenza strains","volume":"13","author":"Coelingh","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.xphs.2019.02.017_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1750-2659.2010.00183.x","article-title":"The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults","volume":"5","author":"Ambrose","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.017_bib8","first-page":"312","article-title":"Influenza virus vaccine live intranasal-MedImmune vaccines: CAIV-T, influenza vaccine live intranasal","volume":"4","year":"2003","journal-title":"Drugs R D"},{"key":"10.1016\/j.xphs.2019.02.017_bib9","first-page":"3","article-title":"Analysis on the epidemiological characteristics of influenza in mainland China in 2015","volume":"14","author":"Chen","year":"2016","journal-title":"J\u00a0Trop Dis Parasitol"},{"key":"10.1016\/j.xphs.2019.02.017_bib10","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1016\/j.vaccine.2016.09.059","article-title":"Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets","volume":"34","author":"Shen","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.xphs.2019.02.017_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biologicals.2014.05.007","article-title":"Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies","volume":"42","author":"Kumru","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.xphs.2019.02.017_bib12","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.addr.2011.07.006","article-title":"Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development","volume":"63","author":"Kamerzell","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2019.02.017_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpc.2006.12.007","article-title":"Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects","volume":"127","author":"Arakawa","year":"2007","journal-title":"Biophys Chem"},{"key":"10.1016\/j.xphs.2019.02.017_bib14","first-page":"297","article-title":"Stability characteristics of freeze-dried human live virus vaccines","volume":"36","author":"Cowdery","year":"1976","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.xphs.2019.02.017_bib15","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1016\/j.vaccine.2016.04.074","article-title":"Development of a stable liquid formulation of live attenuated influenza vaccine","volume":"34","author":"White","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.xphs.2019.02.017_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0166-0934(01)00432-3","article-title":"Stabilizing cold-adapted influenza virus vaccine under various storage conditions","volume":"102","author":"Yannarell","year":"2002","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.xphs.2019.02.017_bib17","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1038\/ncomms13520","article-title":"Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months","volume":"7","author":"Pelliccia","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.xphs.2019.02.017_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2005.05.019","article-title":"Effect of counterions on the physical properties of l-arginine in frozen solutions and freeze-dried solids","volume":"301","author":"Izutsu","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2019.02.017_bib19","series-title":"Study on the Dynamic Changes of Soluble Protein and Free Amino Acids in Fluid of Chicken Embryo","author":"Gu","year":"2012"},{"key":"10.1016\/j.xphs.2019.02.017_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2010.02.025","article-title":"Protein aggregation \u2013 pathways and influencing factors","volume":"390","author":"Wang","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2019.02.017_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijpharm.2016.11.058","article-title":"Strategy for assessment of the colloidal and biological stability of H1N1 influenza A viruses","volume":"517","author":"H\u00e4mmerling","year":"2017","journal-title":"Int J\u00a0Pharm"},{"key":"10.1016\/j.xphs.2019.02.017_bib22","series-title":"Vaccine Development and Manufacturing","first-page":"237","article-title":"Stabilization and formulation of vaccines","author":"Priddy","year":"2014"},{"key":"10.1016\/j.xphs.2019.02.017_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF01121503","article-title":"pH-Dependent hydrophobicity profile of hemagglutinin of influenza virus and its possible relevance in virus fusion","volume":"12","author":"Korte","year":"1992","journal-title":"Biosci Rep"},{"key":"10.1016\/j.xphs.2019.02.017_bib24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2471\/BLT.08.056879","article-title":"Validation of the shake test for detecting freeze damage to adsorbed vaccines","volume":"88","author":"Kartoglu","year":"2010","journal-title":"Bull World Health Organ"},{"issue":"31","key":"10.1016\/j.xphs.2019.02.017_bib25","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1016\/j.vaccine.2011.04.079","article-title":"Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay","volume":"29","author":"Schlehuber","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.xphs.2019.02.017_bib26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1586\/14760584.3.6.643","article-title":"Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine","volume":"3","author":"Belshe","year":"2004","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"10.1016\/j.xphs.2019.02.017_bib27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1586\/14760584.2015.1034695","article-title":"Live attenuated influenza vaccine tetravalent: a clinical review","volume":"14","author":"Bandell","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.xphs.2019.02.017_bib28","doi-asserted-by":"crossref","first-page":"e66316","DOI":"10.1371\/journal.pone.0066316","article-title":"Amechanistic study on the destabilization of whole inactivated influenza virus vaccine in gastric environment","volume":"8","author":"Choi","year":"2013","journal-title":"PLoS One"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919301339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919301339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T04:41:12Z","timestamp":1561092072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354919301339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0022354919301339"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.02.017","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a Stable Liquid Formulation for Live Attenuated Influenza Vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}